周边动脉疾病(PAD) 市场规模、份额和成长分析：按类型、按治疗类型、按疾病、按给药途径、按最终用户、按地区 - 行业预测，2024-2031 年

2022年周边动脉疾病（PAD）市场规模为42.7亿美元，从2023年的46.6亿美元成长到2031年的92.8亿美元，预计复合年增长率为2024年至2031年。

根据研究，美国40岁以上的人中约有650万人患有周边动脉疾病（PAD）。儘管男性和女性都易感，但统计数据显示，非裔美国人患这种疾病的风险更高。随着老龄化，血管疾病变得更加常见，老化显着导致周边动脉疾病（PAD）盛行率的增加。此外，人口老化的加剧与 PAD 诊断、管理和治疗相关产品的核准增加有关。这些因素共同增加了罹患周边动脉疾病(PAD) 的整体风险。人口变化、疾病盛行率上升和医疗技术进步的综合作用凸显了美国与 PAD 相关的危险因子的复杂性。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 成功的关键因素
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

周边动脉疾病（PAD）市场：按类型

• 市场概况
• 周围血管成形术用气球
• 斑块修饰装置
• 外周支架
• 週边导管
• 血流动力学血流调节装置
• 下腔静脉滤器
• 周边设备配件

周边动脉疾病(PAD) 市场：依治疗类型

• 市场概况
• 装置
• 导管
• 药品
• 斑块修饰装置
• 血流动力学血流调节装置
• 其他的

周边动脉疾病（PAD）市场：依疾病分类

• 市场概况
• 降血脂药
• 三氢疗法
• 血糖值调节器
• 预防血栓药物
• 强心药
• 溶栓剂
• 发炎剂

周边动脉疾病(PAD) 市场：依途径

• 市场概况
• 口服
• 胃肠外的
• 其他的

周边动脉疾病(PAD) 市场：依最终用户分类

• 市场概况
• 医院/诊所
• 门诊手术诊所

周边动脉疾病(PAD) 市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Bayer AG（Germany）
• Abbott Laboratories（USA）
• Medtronic（USA）
• Boston Scientific（USA）
• Cook Medical（USA）
• Terumo Corporation（Japan）
• CR Bard（USA）
• Cardinal Health（USA）
• Becton, Dickinson and Company（BD）（USA）
• AngioDynamics（USA）
• Philips Healthcare（Netherlands）
• Biotronik（Germany）
• Straub Medical（Switzerland）
• WL Gore & Associates（USA）
• Endologix（USA）
• Merit Medical Systems（USA）
• Kawasumi Laboratories（Japan）
• Biosensors International（Singapore）
• iVascular（Spain）
• Lepu Medical（China）
• OptiMed（Germany）

Peripheral Artery Disease Market size was valued at USD 4.27 billion in 2022 and is poised to grow from USD 4.66 billion in 2023 to USD 9.28 billion by 2031, growing at a CAGR of 9.80% in the forecast period (2024-2031).

Surveys indicate that around 6.5 million individuals aged 40 and above in the United States are affected by Peripheral Artery Disease (PAD). Both men and women are susceptible, but statistics indicate that African Americans face a higher risk of developing this condition. The aging population significantly contributes to the increasing prevalence of PAD, as vascular diseases become more common with age. Moreover, the ongoing aging of the population correlates with an increase in approvals for products related to the diagnosis, management, and treatment of PAD. Together, these factors heighten the overall risk of developing peripheral arterial disease. The convergence of demographic changes, rising disease prevalence, and advancements in medical technology highlights the complex nature of the risk factors associated with PAD in the United States.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segmental Analysis

The peripheral artery disease market is segmented into product type, route of administration, end user, and region. Based on product type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Peripheral Accessories. Based on the route of administration, the peripheral artery disease market is segmented into oral, parenteral, and others. Based on end users, the peripheral artery disease market is segmented into hospitals & clinics, ambulatory surgical clinics, and others. Based on region, the market is segmented into North America, Asia Pacific, Europe, Middle East & Africa, and Latin America.

Drivers of the Peripheral Artery Disease Market

The increasing prevalence of diabetes and hypertension among elderly populations is a notable risk factor driving the rise in peripheral artery disease (PAD), thereby boosting market demand. Elderly individuals are particularly vulnerable to developing vascular complications, with diabetes and hypertension significantly heightening this risk. These chronic conditions frequently result in the narrowing and hardening of arteries, reducing blood flow to the extremities and escalating the probability of PAD.

Restraints in the Peripheral Artery Disease Market

The expected recurrence of peripheral artery disease (PAD) following treatment is anticipated to present a significant hurdle to the growth of the peripheral arterial disease market in the forecast period. Despite advancements in medical interventions, the possibility of PAD recurring poses a challenge to sustained market expansion. Moreover, concerns about product recalls within the industry could exacerbate difficulties for the peripheral arterial disease market in the near term. Product recalls have the potential to impact consumer confidence, attract regulatory scrutiny, and necessitate corrective actions, all of which may hinder overall growth and stability in the PAD market. Addressing these challenges will require collaborative efforts from stakeholders to navigate the complexities of disease management and ensure the ongoing development of effective solutions in the realm of peripheral arterial disease.

Market Trends of the Peripheral Artery Disease Market

The rising prevalence of peripheral artery diseases (PAD) alongside increasing approvals of new products are key factors projected to create opportunities for growth in the PAD market in the coming years. The growing incidence of PAD, which involves the narrowing of arteries supplying blood to the limbs, underscores the urgent requirement for advanced diagnostic and treatment options. With regulatory bodies consistently approving new products designed to tackle the complexities associated with PAD, the market is set to expand. These approvals signify advancements in medical technology, introducing innovative approaches to diagnose, manage, and treat PAD effectively.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Peripheral Artery Disease Market by Type

• Market Overview
• Peripheral Angioplasty Balloons
• Plaque Modification Devices
• Peripheral Stents
• Peripheral Catheters
• Hemodynamic Flow Alteration Devices
• Inferior Vena Cava Filters
• Peripheral Accessories

Peripheral Artery Disease Market by Treatment Type

• Market Overview
• Devices
• Catheters
• Drugs
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Other

Peripheral Artery Disease Market by Disease

• Market Overview
• Lipid Lowering Drugs
• Triple-H Therapy
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs
• Inotropes
• Thrombolytic Agents
• Anti-Inflammatory Agents

Peripheral Artery Disease Market by Route of Administration

• Market Overview
• Oral
• Parenteral
• Others

Peripheral Artery Disease Market by End Users

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Clinics

Peripheral Artery Disease Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Straub Medical (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iVascular (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMed (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments